Home > Boards > Stock Clubs > Short-Term > OTC Stock Splits (StockSplits)

PMCL - Pharm Control Shareholder Update

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Rager Member Profile
Member Level Grandfathered Member
Followed By 81
Posts 17,987
Boards Moderated 4
Alias Born 05/13/01
160x600 placeholder
Top Company News of the Day
The company said some products showed traces of benzene, a cancer-causing chemical, and that customers should throw the sprays away.
Moderna to Test Variant-Specific Vaccine Candidate
Corn Rises as Agriculture Assets Dodge Broader-Market Sell-Off -- Daily Grain Highlights
Marriott, Hilton and Other Lodging Stocks Down as Variant Concerns Prompt Broad Decline
Uber Down 4%, Lyft Declines 5%
Unemployment Rate Seen Ticking Down Again -- Data Week Ahead
Front Month Nymex RBOB Gasoline Fell 8.25% This Week to Settle at $2.0294 -- Data Talk
Front Month Nymex Natural Gas Rose 7.54% This Week to Settle at $5.4470 -- Data Talk
Correction to European Indexes Data Talks on Nov. 24
STOXX Europe 50 Index Ends the Week 4.41% Lower at 3606.58 -- Data Talk
EURO STOXX 50 Index Ends the Week 6.13% Lower at 4089.58 -- Data Talk
DAX Ends the Week 5.59% Lower at 15257.04 -- Data Talk
CAC 40 Index Ends the Week 5.24% Lower at 6739.73 -- Data Talk
STOXX Europe 600 Index Ends the Week 4.53% Lower at 464.05 -- Data Talk
FTSE 100 Index Ends the Week 2.49% Lower at 7044.03 -- Data Talk
Telenor Appeal to Overturn $87.8 Million Fine Is Rejected by Norwegian Court
Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs
FTSE 100 Closes Friday Down as Latest Coronavirus Variant Sparks Sell-off
Theme Park Stocks Fall Amid Coronavirus Variant Concerns
Covid-19 Vaccine Maker Stocks Higher Amid Variant Concerns
Boeing Down Nearly 8%, On Track for Largest Percent Decrease Since June 2020 -- Data Talk
BioNTech Up Nearly 21%, On Pace for Largest Percent Increase Since May 2020 -- Data Talk
American Express Down Over 8%, Worst Performer in the DJIA So Far Today -- Data Talk
Rager Member Level Grandfathered Member Friday, 05/11/07 09:50:48 AM
Re: None
Post # of 72 
PMCL - Pharm Control Shareholder Update
May 11, 2007 9:45:00 AM
NEW YORK, NY -- (MARKET WIRE) -- 05/11/07 -- The Board of Directors of Pharm Control Ltd. (PINKSHEETS: PMCL) is proud to announce that they have decided to reward patient shareholders with a forward stock split whereby shareholders of record on June 29, 2007 will receive eight (8) new shares for every five (5) shares they hold.

The company intends to proceed with the previously announced stock spin-off of the European distribution company after this dividend is completed.

Pharm Control Ltd. is still in the process of completing its change of transfer agents while awaiting the approval of the new stock symbol by the NASD.

About Pharm Control Ltd.

Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.

Safe Harbor Statement

The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.

Contact:

Pharm Control Ltd.
Eugene Kron
Vice President
Email: pmclinfo@yahoo.com
Tel: (212) 252-4521





Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences